Kamal Matli

Kamal Matli

CLIN AST PROF

Department: MD-CARDIOLOGY
Business Phone: (352) 273-9065
Business Email: kmatli@ufl.edu

On This Page

About Kamal Matli

My name is Dr. Kamal Matli, and I am an interventional and structural cardiologist at UF Health. I treat complex coronary artery disease and structural heart disease using advanced, catheter-based therapies that may allow patients to be treated without open-heart surgery. My areas of focus include complex and high-risk coronary intervention, transcatheter aortic valve replacement (TAVR), transcatheter mitral and tricuspid valve repair and replacement, left atrial appendage closure for stroke prevention, PFO and ASD closure, intravascular imaging, and advanced hemodynamic assessment.

My interest in cardiology is also deeply personal. Cardiovascular disease has affected several members of my family, and early on I wanted to understand heart disease well enough to help the people closest to me. That motivation ultimately grew into something broader: I wanted to develop the expertise to care for every patient with the same sense of responsibility I would have for someone in my own family. What drew me to interventional cardiology was the chance to combine careful clinical reasoning with hands-on skill in a way that makes an immediate, tangible difference in a patient’s life. Your heart is never just a single test result. I look at your symptoms, your anatomy, your imaging and your overall health together to find the treatment that is truly right for you. Sometimes that means performing a complex procedure, and sometimes it means recognizing that a procedure isn’t the best option at all. Either way, I want you to leave my office understanding exactly what I recommend and why.

My training took me through Lebanon, France, Canada and the United States, and each step shaped the physician I am today. I completed medical school and my early cardiology training at Lebanese American University, then pursued advanced cardiology training at the Université de Strasbourg and interventional training at L’Institut Mutualiste Montsouris in Paris, an institution with a longstanding tradition of cardiovascular innovation and a historic role in the development of transcatheter aortic valvetherapies (TAVR). I went on to complete a two-year, Royal College-accredited fellowship ininterventional cardiology at the Université de Montréal and CHUM, followed by advanced fellowship training in structural heart disease at UMass Chan Medical School and UMass Memorial Medical Center, where I also held attending physician responsibilities. Training and practicing across four countries and different health systems has given me abroad perspective on cardiovascular care and allows me to draw on techniques, technologies and advances from leading centers around the world.

One of the parts of medicine I value most is the relationship I build with my patients and their families. Facing coronary artery disease, valve disease or a major heart procedure can be intimidating, and I never want you to feel like just a case on a schedule. My goal is always to keep your care individualized,evidence-based and centered on what matters to you.

Board Certifications

  • Adult Interventional Cardiology
    Diplomate of the Royal College of Physicians and Surgeons of Canada
  • Echocardiography
    Diplomate of the University of Strasbourg – France

Publications

Academic Articles

  1. Diagnostic and prognostic potential of left atrial strain in cardiovascular disease: a narrative review.

    Journal
    Journal of echocardiography.
    Volume/Issue
    23(2):69-85
    [DOI]
    10.1007/s12574-024-00677-5.
    [PMID]
    39731693.
  2. Transcatheter Tricuspid Valve Intervention for the Treatment of Tricuspid Regurgitation with TriClip: All You Need to Know.

    Journal
    Heart international.
    Volume/Issue
    18(1):38-43
    [DOI]
    10.17925/HI.2024.18.1.6.
    [PMID]
    39006467.
  3. Managing endothelial dysfunction in COVID-19 with statins, beta blockers, nicorandil, and oral supplements: A pilot, double-blind, placebo-controlled, randomized clinical trial.

    Journal
    Clinical and translational science.
    Volume/Issue
    15(10):2323-2330
    [DOI]
    10.1111/cts.13369.
    [PMID]
    35808843.
  4. Transcatheter tricuspid valve intervention techniques and procedural steps for the treatment of tricuspid regurgitation: a review of the literature.

    Journal
    Open heart.
    Volume/Issue
    9(1)
    [DOI]
    10.1136/openhrt-2022-002030.
    [PMID]
    35654481.
  5. Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study.

    Journal
    Open heart.
    Volume/Issue
    8(2)
    [DOI]
    10.1136/openhrt-2021-001785.
    [PMID]
    34611018.
  6. Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review.

    Journal
    Open heart.
    Volume/Issue
    8(1)
    [DOI]
    10.1136/openhrt-2021-001628.
    [PMID]
    34099529.
  7. National study on the adequacy of antidotes stocking in Lebanese hospitals providing emergency care.

    Journal
    BMC pharmacology & toxicology.
    Volume/Issue
    17(1)
    [PMID]
    27817746.

Education

  1. Advanced Structural Heart Disease Fellowship

    UMass Memorial Medical Center – Massachusetts,USA

  2. Interventional Cardiology and Structural Heart disease Fellowship

    University of Montreal – CHUM

  3. Advanced Interventional Cardiology Fellowship

    Institut Mutualiste Montsouris – Paris

  4. Cardiology senior year

    University of Strasbourg University Hospitals

  5. Cardiology

    Lebanese American University Medical Center Rizk Hospital

  6. Internal Medicine

    Lebanese American University Medical Center Rizk Hospital

  7. Medical Doctor (MD)

    Lebanese American University

Contact Details

Phones:
Business:
(352) 273-9065
Emails:
Business:
kmatli@ufl.edu
Addresses:
Business Street:
PO Box 100288
GAINESVILLE FL 32610